A share price of Soleno Therapeutics Inc [SLNO] is currently trading at $69.64, up 3.20%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SLNO shares have lost -2.53% over the last week, with a monthly amount glided 55.52%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel reaffirmed its Buy rating on December 02, 2024, and kept the price target unchanged to $74. On December 02, 2024, Robert W. Baird reiterated its Outperform rating but maintained its price target of $72 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $70 on September 03, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $72 as its price target on May 10, 2024. Piper Sandler started tracking with a Overweight rating for this stock on February 05, 2024, and assigned it a price target of $93. In a note dated January 23, 2024, Stifel initiated an Buy rating and provided a target price of $63 on this stock.
Soleno Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $36.61 and $74.00. Currently, Wall Street analysts expect the stock to reach $89.5 within the next 12 months. Soleno Therapeutics Inc [NASDAQ: SLNO] shares were valued at $69.64 at the most recent close of the market. An investor can expect a potential return of 28.52% based on the average SLNO price forecast.
Analyzing the SLNO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.75 and Total Capital is -0.59. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 65.77 points at the first support level, and at 61.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 71.74, and for the 2nd resistance point, it is at 73.84.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Soleno Therapeutics Inc [NASDAQ:SLNO] is 15.68. In addition, the Quick Ratio stands at 15.68 and the Cash Ratio stands at 4.69.
Transactions by insiders
Recent insider trading involved Hirano Patricia C, , that happened on Apr 01 ’25 when 3782.0 shares were sold. Officer, PATRICIA HIRANO completed a deal on Apr 01 ’25 to buy 3782.0 shares. Meanwhile, Director Pauls Matthew sold 5937.0 shares on Mar 28 ’25.
